PT-141 Dosage Guide & Research Calculator
This PT-141 dosage guide pulls together reconstitution math, an embedded concentration calculator, and dose ranges for the melanocortin-receptor agonist PT-141 reported in published preclinical and clinical-pharmacology research literature. All figures below summarize parameters reported in published preclinical or in-vitro research. They are provided for reference only and are not instructions for human or veterinary administration.
For laboratory and research use only. Not for human or veterinary use. The information below summarizes dosing parameters reported in published research and is provided for reference only — not as guidance for administration.
PT-141 reconstitution math & pt-141 dosage calculator
Reconstituting a lyophilized peptide gives a solution with a known concentration. The formula is simple:
Worked example: Adding 2 mL of bacteriostatic water to a 10 mg vial of PT-141 yields 5,000 mcg/mL. 0.20 mL (20 units on a U-100 insulin syringe) of that solution contains 1,000 mcg (1 mg) of peptide.
Enter your values
The total mass of lyophilized powder listed on the vial label.
The volume of bacteriostatic water added to the vial.
The amount, in micrograms, to model in your concentration math (1 mg = 1,000 mcg).
Display volume in U-100 syringe units or plain mL.
Based on your inputs
This tool performs unit conversion and concentration math for research planning. It is not medical advice, not a dose recommendation, and not intended for human or veterinary use.
PT-141 doses reported in published preclinical research
The figures below summarize PT-141 doses that appear in published animal-model or in-vitro studies. They describe what researchers have used in laboratory settings — they are not human administration protocols and are not dose recommendations.
| Research context | Dose reported | Notes |
|---|---|---|
| Published clinical-pharmacology trials, subcutaneous | 0.3–1.75 mg | Single-dose range reported in published trial literature. |
| Published clinical-pharmacology trials, intranasal | 5–20 mg | Range explored in published early intranasal research. |
| Preclinical rodent studies | 0.1–1 mg/kg | Subcutaneous ranges in animal-model melanocortin literature. |
All values are research-context references compiled from published preclinical and in-vitro literature. PT-141 is supplied for laboratory and research use only.
Continue your PT-141 research
PT-141 research dosage — frequently asked questions
How is PT-141 reconstituted for research?+
Lyophilized PT-141 is dissolved in bacteriostatic water in the laboratory. Concentration is calculated as (vial mg × 1000) ÷ diluent mL, giving mcg per mL.
What concentration does 10 mg PT-141 in 2 mL give?+
10 mg in 2 mL of bacteriostatic water yields a 5,000 mcg/mL solution. 0.20 mL (20 units on a U-100 insulin syringe) contains 1,000 mcg (1 mg).
What PT-141 doses are reported in published research?+
Published clinical-pharmacology trials reference subcutaneous single doses of roughly 0.3–1.75 mg and intranasal doses of 5–20 mg. Preclinical rodent studies report subcutaneous ranges of 0.1–1 mg/kg.
Is this PT-141 dosage guide for human use?+
No. PT-141 is supplied for laboratory and research use only. The figures above describe parameters reported in published research and are not human administration instructions.
For laboratory and research use only. Not for human or veterinary use. The information below summarizes dosing parameters reported in published research and is provided for reference only — not as guidance for administration.